We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Pays States $14 Million To Settle Paxil Dispute
GSK Pays States $14 Million To Settle Paxil Dispute
April 4, 2006
GlaxoSmithKline (GSK) said it would pay states $14 million to resolve allegations it illegally blocked generic entry to the market of its antidepressant Paxil, which caused state healthcare plans to pay higher prices for the drug.